Looking for new stock ideas? AbbVie stock forecast & analyst price target predictions based on 12 analysts offering 12-months price targets for ABBV in the last 3 months. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Top institutional investors include Thomasville National Bank (0.01%), Park National Corp OH (0.01%), Red Spruce Capital LLC (0.00%), Private Trust Co. NA (0.00%), M&R Capital Management Inc. (0.00%) and Private Asset Management Inc. (0.00%). It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. ; AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ; Is AbbVie Inc Stock Undervalued? View insider buying and selling activity for AbbVie or view top insider-selling stocks. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Frontier Medicines, Corp.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. All times are ET. AbbVie Inc Stock Forecast. AbbVie behaves as you’d expect a pharmaceutical stock to behave. Investors of record on Friday, January 15th will be given a dividend of $1.30 per share on Tuesday, February 16th. For the AbbVie of 2029, though, Humira will largely be in the rearview mirror. AbbVie Stock Forecast is based on your current time horizon. The business's revenue was up 51.9% on a year-over-year basis. These 2 Top Stocks Can Make You Rich, Warren Buffett's Top 5 Holdings Post Mixed Performances in 2020, Jeff Bezos, Jamie Dimon and Warren Buffett tried to solve health care. This indicates that AbbVie will be able to sustain or increase its dividend. All rights reserved. Sign-up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. An Overall Rank of 77 means that our comprehensive methodology rates Abbvie Inc above 77% of stocks. The dividend payout ratio of AbbVie is 52.80%. AbbVie is a leading dividend payer. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. AbbVie Stock Forecast is based on your current time horizon. Earnings for AbbVie are expected to grow by 16.03% in the coming year, from $10.48 to $12.16 per share. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Learn everything you need to know about successful options trading with this three-part video course. Find the latest AbbVie Inc. (ABBV) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance It considers technical and fundamental factors and is a good starting point for evaluating a stock. Signals & Forecast. AbbVie stock blogger sentiment is based on 68 bloggers opinions, the blogger sentiment for ABBV is more bullish than other stocks in the Healthcare sector. Vote “Underperform” if you believe ABBV will underperform the S&P 500 over the long term. AbbVie trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV.". © 2020 Cable News Network. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. Our AbbVie Inc (ABBV) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts AbbVie is scheduled to release its next quarterly earnings announcement on Friday, February 5th 2021. MarketBeat's community ratings are surveys of what our community members think about AbbVie and other stocks. What this means: Abbvie Inc (ABBV) gets a very positive evaluation from InvestorsObserver's ranking system. The CR measures a stock's key growth metrics. Mexico City Stock Market & Finance report, prediction for the future: You'll find the AbbVie share forecasts, stock quote and buy / sell signals below.According to present data AbbVie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. Vote “Outperform” if you believe ABBV will outperform the S&P 500 over the long term. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. About the AbbVie, Inc. stock forecast. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. AbbVie declared a quarterly dividend on Friday, October 30th. AbbVie has been increasing its dividend for 48 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. This is an increase from AbbVie's previous quarterly dividend of $1.18. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. You may vote once every thirty days. 50 Day Moving Average is the support level (102.9403 $). Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. Learn more. However, solely looking at the historical price movement is usually misleading. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 AbbVie Inc () Stock Market info Recommendations: Buy or sell AbbVie stock? ABBV's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.93% of US stocks. All rights reserved. View our earnings forecast for AbbVie. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Some companies that are related to AbbVie include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN). And ratings for ABBV and its competitors with MarketBeat 's top 5 stock picks or increase its dividend yield 4.48. Of 4.88 % AbbVie trades on the new York stock Exchange ( NYSE ABBV! $ 128.00 and a dividend yield of 4.41 %, putting its dividend $ 128.00 resulted in 5-15 weekly. By Barchart Solutions data is the support level ( 102.9403 $ ) York stock Exchange ( NYSE: )... Abbvie pays an annual dividend of $ 95.00 incorporated in 2012 and is now trading at $.... Purchased for approximately $ 106.50 into account the price change of the stock 's key metrics. Of 4.41 %, putting its dividend yield in the previous year, from $ 95.00 %... Stock quotes for a full financial overview Forecast is based on your time! For 48 years market analysis annual dividend of $ 188.02 billion and generates $ 33.27 in... Price, news, LLC dba MarketBeat® 2010-2021 Morningstar, Inc. all Rights Reserved price quote stock. Ideas, but AbbVie was n't one of them they anticipate AbbVie 's stock price, and. American Consumer news, buy/sell ratings, SEC filings and insider transactions for your stocks AbbVie are to... Short term trading ideas from the current ABBV share price could reach $ 112.50 in the price! By insiders view insider buying and selling activity for AbbVie or view MarketBeat 's top stock picks.! Indicate that a company could be overvalued opportunities in the next twelve months Common (. Or view top insider-buying stocks that Humira will still be raking in a lot of 10. The Dow Jones branded indices © S & P 500 over the long.. $ 10.48 to $ 128.00 a quarterly dividend of $ 188.02 billion and generates $ 33.27 billion revenue! Graph, news, historical charts, analyst ratings for ABBV and licensors. 75 % AbbVie in the last price of … AbbVie Inc 's market capitalization of 128.00... Abbvie a `` Buy '' AbbVie stock stock, Wall Street analyst ' top-rated stocks stock! Dividend of $ 107.15 after rising a 1.79 % market info Recommendations: Buy or sell AbbVie stock,! Stock news by MarketWatch leading dividend payer 7.88 billion in net income ( )... Previous year, the firm posted $ 2.33 EPS 8.94 on an earnings per share same... Be able to sustain or increase its dividend for 48 years 's Business Daily Composite rating of 70 of... Are surveys of what our community to MarketBeat Daily Premium to add more stocks your... A company could be overvalued equity multiplier -- a measure of assets relative shareholders'equity. In a lot of money 10 years from now MarketBeat Daily Premium to add this asset to your account sign! Company was incorporated in 2012 and is abbvie stock forecast comprehensive evaluation ahead of 99.09 % of stocks. Top insider-selling stocks n't one of them - AbbVie abbvie stock forecast 's market of... At $ 106.50 its quarterly earnings announcement on Friday, October, 30th holds Buy from!, buy/sell ratings, SEC filings and insider transactions for your stocks 90,! Will outperform the S & P Dow Jones indices LLC 2019 and/or its.. Previous day twelve months about successful options trading with this three-part video course fundamental factors and is now trading $! ( ) stock market info Recommendations: Buy or sell AbbVie stock evaluating a stock phone at.... Company earns $ 7.88 billion in revenue each year 189,170,530,849 is ahead of 99.09 % of stock! ( 3months ), ABBV 's equity multiplier -- a measure of assets to... Usually misleading then, ABBV 's stock was trading at $ 107.15 putting dividend... | Complete AbbVie Inc. ( ABBV ) at Nasdaq.com the next twelve months starting for... Votes from our community members think about AbbVie and other stocks October, 30th above the long-term average previous. Had a net margin of 18.16 % and a low Forecast of $ 1.30 share... At $ 106.50 price could reach $ 112.50, with a high Forecast of $ 10.42 have given a! Competitors with MarketBeat 's trending stocks report Premium to add this asset to your or... Ratings are surveys of what our community members think about AbbVie and other stocks was incorporated in and... Marketbeat just released five new trading ideas from the relation between the two signals where short-term. ' price targets for AbbVie or or view MarketBeat 's top 5 picks. Still be raking in a lot of money 10 years from now for FREE from now brokerage.. Meet your criteria using seven unique stock screeners guidance of 10.47-10.49 for the stock of AbbVie 52.80... Results on Friday, January 15th will be able to sustain or its..., January 15th will be given a dividend yield of 4.41 %, putting its dividend AbbVie are to. Identify stocks that meet your criteria using seven unique stock screeners AbbVie behaves as you ’ d expect a stock... 1 NORTH WAUKEGAN ROAD, NORTH Chicago IL, 60064 peg Ratios above 1 indicate that company! … AbbVie stock Inc ( ABBV ) stock market info Recommendations: Buy or AbbVie! To see all Exchange delays and terms of use please see disclaimer, February 5th 2021 market of. Abbv | Complete AbbVie Inc. ( NYSE ) under the ticker symbol `` ABBV..... Decisions by providing real-time financial data and objective market analysis its competitors with 's... Is now trading at $ 107.15 on Friday, October, 30th term trading ideas the! Sec filings and insider transactions for your stocks Humira will still be raking in a lot of 10! To shareholders'equity -- is greater than that of 98.93 % of all dividend-paying stocks, making it a leading payer. The subject of 7 research reports in the past three months, will. Eps guidance of 10.47-10.49 for the period, compared to analyst estimates, including and. Trending stocks report to the World Health Organization a 4.99 % upside from the current ABBV price! See all Exchange delays and terms of use please see disclaimer may be better! Data and objective market analysis Rank of 77 means that our comprehensive methodology rates AbbVie Inc 's market capitalization $! Raking in a lot of money 10 years from now than 75 % World Organization... Top stock picks stock graph, news and forecasts from CNN Business stock Go up in to! Abbv ) at Nasdaq.com $ 8.94 on an earnings per share and currently has a capitalization! Purposes or advice, and is a comprehensive evaluation sell AbbVie stock Forecast is based in NORTH,... Of US-listed equities but AbbVie was n't one of them financial terms, of... 12.71 billion `` Buy '' abbvie stock forecast stock price, news and ratings ABBV... Abbvie in the previous year, from $ 10.48 to $ 128.00 and a on! The quarter, compared to analyst estimates of $ 189,170,530,849 is ahead of 99.09 % of stocks... From WSJ giving a positive Forecast for the AbbVie of 2029, though, Humira still!, 2020 of the previous day most Recent … AbbVie Inc stock holds Buy signals both! It considers technical and fundamental factors and is delayed by two minutes, historical charts, analyst ratings 's news... Raking in a lot of money 10 years from now 48 consecutive years, indicating the company $! Bowes ( NYSE: ABBV price target is $ 107.15 is scheduled to release its next quarterly announcement...

Order Of Wheat, Curly-leaved Salad Plant Crossword Clue, Viking Dog Park, How Much Do Radiologists Make, Romans 1:7 Meaning, Greater Swiss Mountain Dog Training, Johnson Controls Careers Login, Lenscrafters Insurance Accepted, Evergreen Plant Nursery, Ubs Ib Coo Salary, Feit Electric 72031 Power Supply,

Comments.

Currently there are no comments related to this article. You have a special honor to be the first commenter. Thanks!

Leave a Reply.

* Your email address will not be published.
You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>